OpenEvidence
| Private | |
| ISIN | 🆔 |
| Industry |
|
| Founded 📆 | 2021 |
| Founders 👔 |
|
Area served 🗺️ | |
Key people | Daniel Nadler (CEO) |
| Products 📟 |
|
| Members | |
Number of employees | |
| 🌐 Website | www |
| 📇 Address | |
| 📞 telephone | |
OpenEvidence, Inc. is an American medical artificial intelligence (AI) company. Its platform allows verified physicians to search across more than 35 million peer‑reviewed publications and receive referenced answers at the point of care.[1][2] As of July 2025, the system is used daily by over 40 percent of U.S. physicians and in more than 10,000 hospitals and medical centers.[2][3]
History
Harvard-trained AI scientists Daniel Nadler and Zachary Ziegler founded OpenEvidence in 2021 in Cambridge, Massachusetts.[4][5] In 2025, the company moved its headquarters to Miami, Florida.[6]
A $75 million Series A led by Sequoia Capital in February 2025 valued the company at $1 billion.[4] In July 2025, OpenEvidence announced a $210 million Series B co-led by GV and Kleiner Perkins, Conviction and Coatue Management, raising its valuation to $3.5 billion and bringing total funding to more than $300 million.[7][8]
In August 2025, the company's models scored 100% on the US Medical Licensing Exam.[9]
Partnerships
OpenEvidence has licensing agreements with major publishers, including The New England Journal of Medicine and JAMA and its eleven specialty journals, allowing full‑text material to inform answers.[3][1]
Reception
Observers have compared the platform's impact to Google's effect on general web search.[8][10] John Doerr of Kleiner Perkins described it as “a life‑saving resource for doctors, patients and their families" and said “I think OpenEvidence looks like it's going to be for healthcare what Google was for the Internet.”[8]
See also
References
- ↑ 1.0 1.1 "Partnering with OpenEvidence". Coatue. 16 June 2025. Retrieved 26 July 2025.
- ↑ 2.0 2.1 "OpenEvidence: Expanding the world's collective medical knowledge". Kleiner Perkins. 15 July 2025. Retrieved 26 July 2025.
- ↑ 3.0 3.1 Zeb, Sangeen (15 July 2025). "OpenEvidence: The Leading AI App for Doctors". GV. Retrieved 26 July 2025.
- ↑ 4.0 4.1 Rooney, Kate (19 February 2025). "AI health‑care startup OpenEvidence raises funding from Sequoia at $1 billion valuation". CNBC. Retrieved 26 July 2025.
- ↑ "OpenEvidence raises $210M on $3.5B valuation to expand AI‑powered medical search and decision tools". SiliconANGLE. 15 July 2025. Retrieved 26 July 2025.
- ↑ Feldman, Amy. "OpenEvidence Cofounder Daniel Nadler Is Now A Billionaire". Forbes. Retrieved 2025-07-26.
- ↑ "OpenEvidence, the Fastest‑Growing Application for Physicians in History, Announces $210 Million Round at $3.5 Billion Valuation" (Press release). OpenEvidence. 15 July 2025. Retrieved 26 July 2025.
- ↑ 8.0 8.1 8.2 Feldman, Amy (15 July 2025). "This AI Founder Became A Billionaire By Building ChatGPT For Doctors". Forbes. Retrieved 26 July 2025.
- ↑ Landi, Heather (2025-08-15). "OpenEvidence AI scores 100% on USMLE, launches explanation model". Fierce Healthcare. Retrieved 2025-09-09.
- ↑ "Partnering with OpenEvidence: A Life‑Saving Healthcare Revolution". Sequoia Capital. 19 February 2025. Retrieved 26 July 2025.
External links
This article "OpenEvidence" is from Wikipedia. The list of its authors can be seen in its historical and/or the page Edithistory:OpenEvidence. Articles copied from Draft Namespace on Wikipedia could be seen on the Draft Namespace of Wikipedia and not main one.
